Key result
Achilles tendon thickness correlates weakly with carotid intima-media thickness and links to CAD in non-FH patients.
Why the study?
Although Achilles tendon thickness is an important diagnostic tool for familial hypercholesterolemia, its associations with atherosclerotic diseases and risk factors in non-familial hypercholesterolemia patients remain limited and unclear.
Does increased Achilles tendon thickness correlate with systemic atherosclerosis and cardiometabolic risk factors in non-familial hypercholesterolemia patients?
Cross-Sectional (n=1,000)
No
Does increased Achilles tendon thickness correlate with systemic atherosclerosis and cardiometabolic risk factors in non-familial hypercholesterolemia patients?
Effect estimate: r = 0.088
p-value: p=0.005
Ultrasonographic measurement of Achilles tendon thickness may serve as a useful non-invasive surrogate marker for systemic atherosclerosis and cardiometabolic risk in patients without familial hypercholesterolemia.
ATT associated with carotid IMT and atherosclerotic conditions in non-FH patients; leaves open independent value beyond age.
Background: Achilles tendon thickness (ATT) is an important diagnostic tool for familial hypercholesterolemia (FH), a highly atherogenic genetic disorder. Although the available evidence remains limited, recent studies have reported associations between ATT and atherosclerotic diseases and their risk factors among non-FH patients. We investigated the relationships among ATT, carotid intima-media thickness (IMT), a marker of systemic atherosclerosis, and atherosclerotic risk factors, including diabetes, dyslipidemia, and atherosclerotic diseases, in non-FH patients. Methods: This cross-sectional survey was conducted at the National Kohnodai Medical Center, Japan. Patients who underwent ultrasonographic measurements of both ATT and carotid IMT were included. Clinical data were obtained using medical records and included demographic characteristics, anthropometric measurements, blood pressure, comorbidities, and biochemical parameters. Results: A total of 1,000 patients (512 males, 488 females) were enrolled. The mean age was 65 ± 14 years, the mean body mass index (BMI) was 24.6 ± 4.9 kg/m2, and the mean ATT was 4.6 ± 0.8 mm. ATT was positively correlated with maximal carotid IMT (r = 0.088, P = 0.005), body weight (r = 0.279, P < 0.001), and BMI (r = 0.183, P < 0.001), and inversely correlated with serum levels of high-density lipoprotein-cholesterol (HDL-C) (r = −0.182, P < 0.001). In the multiple regression model that included maximal carotid IMT, BMI, HDL-C, and low-density lipoprotein-cholesterol, the correlations of ATT with maximal carotid IMT, BMI, and HDL-C remained significant; however, the correlation between ATT and maximal carotid IMT was no longer significant in the model added with age. Patients with CAD and carotid artery stenosis had significantly greater ATT than those without such diseases. Similarly, ATT values were higher in patients with diabetes, and those with diabetes and CAD had the highest ATT values. Conclusion: ATT levels were significantly associated with BMI and dyslipidemia, and were significantly higher in non-FH patients with CAD, carotid artery stenosis, and diabetes than in non-FH patients without such diseases.
No takes yet. Share an insight, caveat, or question.
Hakoshima et al. (2026) conducted a cross-sectional in Non-Familial Hypercholesterolemia (n=1,000). Achilles tendon thickness (ATT) vs. Patients without atherosclerotic diseases or diabetes / continuous exposure was evaluated on Correlation between ATT and maximal carotid intima-media thickness (IMT) (r = 0.088, p=0.005). Achilles tendon thickness was significantly correlated with maximal carotid IMT (r=0.088), BMI, and HDL-C, and was elevated in non-FH patients with CAD, carotid artery stenosis, and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: